About this market
Vendors are developing new RSV diagnostics products with increased efficiencies. These launches will contribute to the revenue of companies, which will drive the market. These advanced product launches will make products accessible for end- users and will decrease the time required for diagnostics. The analysts have predicted that the respiratory syncytial virus (RSV) diagnostics market will register a CAGR of over 9% by 2023.
Market Overview
Growing number of M&A
Core reference laboratories or large laboratories are focusing on increasing their presence in the global market through M&A. hence, large laboratories are acquiring small and medium- sized laboratories which conduct testing on infectious diseases.
Product recalls
Product recalls affect the sales and earnings of vendors for short periods and adversely impact their operations for extended periods. Therefore, the recalls of medical products or assays can limit the adoption of other systems and consumables developed by these companies.
For the detailed list of factors that will drive and challenge the growth of the respiratory syncytial virus (RSV) diagnostics market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be fragmented and with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.